DPIIT recognised startup Government of India
Startup India
Hepa Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹19.94 Cr
▲ 267% YoY
Net profit · FY 2024
₹1.09 Cr
Net margin 5.5%
EBITDA · FY 2024
₹1.57 Cr
EBITDA margin 7.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Hepa Pharma Private Limited
Data last updated:
Hepa Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2020PTC142664. Its GSTIN is 36AAFCH3759P1ZW (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Venkateswara Rao Yarrabathina and Sudheer Kumar Darapureddi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.94 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.09 Cr (net margin 5.5%) and EBITDA of ₹1.57 Cr (EBITDA margin 7.9%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years.
The company is associated with 1 brand: Hepa Pharma.
Hepa Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0010458). For more details, the company can be reached via its website hepapharma.com.
Company details
CIN U24100TG2020PTC142664
Registration Number 142664
Incorporation Date 10 August 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification MSME
Udyam Registration UDYAM-TS-02-0010458
Key People
Venkateswara Rao Yarrabathina Additional Director Sudheer Kumar Darapureddi Additional Director Recognitions & Rankings of Hepa Pharma
MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-02-0010458
Contact details
Hepa Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is hepapharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressNo. 1008 10th Floor Manjeera Trinity Corporate, Jntu – Hitech City Road, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hepa Pharma Private Limited, buy the company report.
Comprehensive company report
Hepa Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hepa Pharma operates one associated brand: Hepa Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers comprehensive API development services for clients. | hepapharma.com |
Business activity
The main business activity of Hepa Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hepa Pharma Private Limited, buy the company report.
Financials of Hepa Pharma Private Limited
FY 2025 filings availableHepa Pharma Private Limited reported revenue of ₹19.94 Cr (up 267% YoY) for FY 2024.
Revenue · FY 2024
₹19.94 Cr ▲ 267%
Net profit · FY 2024
₹1.09 Cr margin 5.5%
EBITDA · FY 2024
₹1.57 Cr margin 7.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 267%
3 years · compounded
▼ 4%
EBITDA CAGR growth
3 years · compounded
▲ 17%
Revenue rose 267% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 4%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.57 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.09 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.9% | |||
| Net Profit Margin | 5.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Hepa Pharma Private Limited, buy the company report.
Board of directors of Hepa Pharma Private Limited
Hepa Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkateswara Rao Yarrabathina | Additional Director | 04 Sep 2021 | 5 Years 1 Months | Current |
| Sudheer Kumar Darapureddi | Additional Director | 09 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Hepa Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Escientia Biopharma Private Limited | ₹20.04 Cr (FY 2025) | -79.0% | Hyderabad, Telangana, India | |||
| Engrow Carbon Energy Private Limited | ₹20.04 Cr (FY 2024) | 76.0% | Erode, Tamil Nadu, India | |||
| Ashri Medico Surgicals Private Limited | ₹20.03 Cr (FY 2025) | 27.0% | Indore, Madhya Pradesh, India | |||
| Rescon India Pvt Ltd | ₹20.01 Cr (FY 2023) | 19.0% | Kolkata, West Bengal, India | |||
| Indusbio Organics Private Limited | ₹20 Cr (FY 2024) | 2898451.0% | Bhadesar, Rajasthan, India | |||
| Hepa Pharma Private Limitedthis company | ₹19.94 Cr (FY 2024) | ₹1.09 Cr | 5.5% | 267.0% | Hyderabad, Telangana, India | |
| Allen Healthcare Co Limited | ₹19.94 Cr (FY 2025) | 6.0% | Kolkata, West Bengal, India | |||
| Shaurya Organics Private Limited | ₹19.92 Cr (FY 2025) | -9.0% | Ahmedabad, Gujarat, India | |||
| Flavrich Flavours Andfragrances Private Limited | ₹19.92 Cr (FY 2024) | 15.0% | Haryana, India | |||
| Niconia Chemicals Private Limited | ₹19.91 Cr (FY 2025) | 650.0% | Bathinda, Punjab, India | |||
| Kelvin Bio Organics Private Limited | ₹19.91 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Hepa Pharma Private Limited, buy the company report.
Auditor
Hepa Pharma Private Limited is audited by THOTA SUBBA RAO & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THOTA SUBBA RAO & CO | FY 2021 | 013223S |
Legal cases
No court or tribunal cases involving Hepa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hepa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hepa Pharma Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
Active EPFO establishments
1
GST
Hepa Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCH3759P1ZW | Telangana | Active | 08 Nov 2020 |
To see the full GST registrations and return filing status of Hepa Pharma Private Limited, buy the company report.
Recent activity
Hepa Pharma Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Chandana Venkateswara Rao ceased to be Additional Director on 09 Aug 2024.
AGM
Hepa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hepa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Chandana Venkateswara Rao ceased to be Additional Director.
Appointed
Sudheer Kumar Darapureddi was appointed as Additional Director.
Ceased
Jyothi Vantikommu ceased to be Director.
Appointed
Venkateswara Rao Yarrabathina was appointed as Additional Director.
Ceased
Dharma Rao Bandi ceased to be Director.
Incorporation
10 Aug 2020
Hepa Pharma Private Limited was registered on 10 Aug 2020 with Roc Hyderabad & aged 6 years 2 months as per MCA records.
Frequently asked questions
Hepa Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 August 2020 (6+ years old) and is registered under CIN U24100TG2020PTC142664.
Hepa Pharma has 2 current directors:
- Venkateswara Rao Yarrabathina - Additional Director
- Sudheer Kumar Darapureddi - Additional Director
The latest financial statements of Hepa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Hepa Pharma is 36AAFCH3759P1ZW, registered in Telangana.
The CIN (Corporate Identification Number) of Hepa Pharma is U24100TG2020PTC142664. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hepa Pharma was incorporated on 10 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Hepa Pharma by revenue are Escientia Biopharma Private Limited, Engrow Carbon Energy Private Limited, Ashri Medico Surgicals Private Limited, Rescon India Pvt Ltd, Indusbio Organics Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandana Venkateswara Rao ceased to be Additional Director on 09 Aug 2024. Sudheer Kumar Darapureddi was appointed as Additional Director on 09 Aug 2024. Jyothi Vantikommu ceased to be Director on 04 Sep 2021. Hepa Pharma has 5 board changes on record in total.
Yes, Hepa Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Hepa Pharma is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0010458).
Hepa Pharma can be reached through the website hepapharma.com. Its registered office is in Hyderabad, Telangana, India.